Literature DB >> 23719086

Susceptibility of enterococci to daptomycin is dependent upon testing methodology.

Kendall A Bryant1, Amity L Roberts, Mark E Rupp, James R Anderson, Elizabeth R Lyden, Paul D Fey, Trevor C Van Schooneveld.   

Abstract

An increase in daptomycin nonsusceptible enterococci (DNSE) was noted in our institution (8.3% 2008 to 34.5% 2011) using MicroScan methods which may overestimate DNSE prevalence. DNSE (N = 150) from the clinical laboratory (2008-2011) underwent susceptibility testing using broth microdilution (BMD), Etest, Sensititire, MicroScan prompt (MSP), and MicroScan turbidity (MST) with only 20% of isolates confirmed as nonsusceptible. Categorical and essential agreement were highest with MSP and MST, but both missed the majority of resistant isolates (70% and 87% missed). Etest MIC values were statistically higher, more likely to be nonsusceptible, had the lowest very major error rate (37%), and the highest falsely nonsusceptible rate (22%). Sensititre MIC values were not statistically different from BMD, but missed 57% of DNSE. PFGE analysis did not define a clonal outbreak. These findings suggest that MicroScan methods overestimate nonsusceptibility, and the lack of correlation between methods raises questions regarding which method is most effective at confirming nonsusceptibility.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Daptomycin; Enterococcus; Susceptibility testing

Mesh:

Substances:

Year:  2013        PMID: 23719086     DOI: 10.1016/j.diagmicrobio.2013.04.019

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  6 in total

1.  Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faecium.

Authors:  Clare L Kinnear; Twisha S Patel; Carol L Young; Vincent Marshall; Duane W Newton; Andrew F Read; Robert J Woods
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

2.  Comparison of commercial antimicrobial susceptibility test methods for testing of Staphylococcus aureus and Enterococci against vancomycin, daptomycin, and linezolid.

Authors:  Stefan Riedel; Kar Mun Neoh; Stephen W Eisinger; Lisa M Dam; Tsigereda Tekle; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2014-04-09       Impact factor: 5.948

3.  Performance of Vitek 2 for antimicrobial susceptibility testing of Staphylococcus spp. and Enterococcus spp.

Authors:  April M Bobenchik; Janet A Hindler; Carmen L Giltner; Sandra Saeki; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

4.  Identification of a novel clone, ST736, among Enterococcus faecium clinical isolates and its association with daptomycin nonsusceptibility.

Authors:  Guiqing Wang; Sitharthan Kamalakaran; Abhay Dhand; Weihua Huang; Caroline Ojaimi; Jian Zhuge; Leslie Lee Yee; Pramod Mayigowda; Pavan Kumar Makam Surendraiah; Nevenka Dimitrova; John T Fallon
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

5.  Rapid emergence of daptomycin resistance in clinical isolates of Corynebacterium striatum… a cautionary tale.

Authors:  E McElvania TeKippe; B S Thomas; G A Ewald; S J Lawrence; C-A D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-28       Impact factor: 3.267

6.  Systematic evaluation of commercial susceptibility testing methods for determining the in vitro activity of daptomycin versus Staphylococcus aureus and Enterococci.

Authors:  Thomas J Kirn; Elizabeth Onyeaso; Madiha Syed; Melvin P Weinstein
Journal:  J Clin Microbiol       Date:  2014-03-19       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.